Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ATGAM INTRAVENOUS INFUSION 250mg GENERAL INVESTIGATION

NCT06039020 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT06039020
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06039020 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ATGAM INTRAVENOUS INFUSION 250mg GENERAL INVESTIGATION
Lead sponsor
Pfizer
Phase
Observational
Overall status
Active, not recruiting
Start date
February 21, 2024
Completion date
January 22, 2027
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aplastic anemia